Layla Zulfa

Familial History Linked to "Fragile" Remission in Thyroid Cancer: New Study Challenges Standard Surveillance familial-history-linked-to-fragile-remission-in-thyroid-cancer-new-study-challenges-standard-surveillance

Layla Zulfa May 9, 2026

A recent study published in the medical journal Cancers (2026) has introduced a critical shift in how...

Redefining the Frontier: Navigating Evidence Generation for Ultra-Rare Diseases redefining-the-frontier-navigating-evidence-generation-for-ultra-rare-diseases

Layla Zulfa May 9, 2026

The development of therapies for ultra-rare diseases—conditions affecting fewer than 1,000, and sometimes fewer than 10, individuals—represents...

Recalculating: Navigating the Uncharted Territory of a Cancer Diagnosis recalculating-navigating-the-uncharted-territory-of-a-cancer-diagnosis

Layla Zulfa May 9, 2026

By Investigative Health Desk April 16, 2026 The journey through a cancer diagnosis is rarely a straight...

Beyond the Plate: How Shanti’s ‘Meals Heal’ Program is Confronting the Epidemic of Loneliness beyond-the-plate-how-shantis-meals-heal-program-is-confronting-the-epidemic-of-loneliness

Layla Zulfa May 9, 2026

Introduction: A Silent Crisis in Plain Sight In May 2023, U.S. Surgeon General Dr. Vivek Murthy issued...

Empowering Progress: METAVIVOR Launches 2026 Grant Cycle Amidst a Landscape of Hope and Innovation empowering-progress-metavivor-launches-2026-grant-cycle-amidst-a-landscape-of-hope-and-innovation

Layla Zulfa May 9, 2026

By Editorial Staff As the medical community continues to push the boundaries of oncology, the quest for...

METAvivor Advocacy Update: Navigating the FY 2027 Budget and Strengthening the Metastatic Breast Cancer Voice metavivor-advocacy-update-navigating-the-fy-2027-budget-and-strengthening-the-metastatic-breast-cancer-voice

Layla Zulfa May 8, 2026

As the first quarter of 2026 draws to a close, the METAvivor advocacy team is intensifying its...

Breakthrough in Pathology: New Molecular Markers Identified to Distinguish Between Rare Langerhans Cell Neoplasms breakthrough-in-pathology-new-molecular-markers-identified-to-distinguish-between-rare-langerhans-cell-neoplasms

Layla Zulfa July 23, 2025

Main Facts: Solving a Diagnostic Dilemma Langerhans cell sarcoma (LCS) is an exceptionally rare, highly aggressive malignant...

You may have missed